Objective
To predict intra‐operative (IOEs) and postoperative events (POEs) consequential to the derailment of the ideal clinical course of patient recovery.
Materials and Methods
The Vattikuti Collective Quality Initiative is a multi‐institutional dataset of patients who underwent robot‐assisted partial nephectomy for kidney tumours. Machine‐learning (ML) models were constructed to predict IOEs and POEs using logistic regression, random forest and neural networks. The models to predict IOEs used patient demographics and preoperative data. In addition to these, intra‐operative data were used to predict POEs. Performance on the test dataset was assessed using area under the receiver‐operating characteristic curve (AUC‐ROC) and area under the precision‐recall curve (PR‐AUC).
Results
The rates of IOEs and POEs were 5.62% and 20.98%, respectively. Models for predicting IOEs were constructed using data from 1690 patients and 38 variables; the best model had an AUC‐ROC of 0.858 (95% confidence interval [CI] 0.762, 0.936) and a PR‐AUC of 0.590 (95% CI 0.400, 0.759). Models for predicting POEs were trained using data from 1406 patients and 59 variables; the best model had an AUC‐ROC of 0.875 (95% CI 0.834, 0.913) and a PR‐AUC 0.706 (95% CI, 0.610, 0.790).
Conclusions
The performance of the ML models in the present study was encouraging. Further validation in a multi‐institutional clinical setting with larger datasets would be necessary to establish their clinical value. ML models can be used to predict significant events during and after surgery with good accuracy, paving the way for application in clinical practice to predict and intervene at an opportune time to avert complications and improve patient outcomes.
Current liver transplantation (LT) organ allocation relies on Model for End‐Stage Liver Disease–sodium scores to predict mortality in patients awaiting LT. This study aims to develop neural network (NN) models that more accurately predict LT waitlist mortality. The study evaluates patients listed for LT between February 27, 2002, and June 30, 2021, using the Organ Procurement and Transplantation Network/United Network for Organ Sharing registry. We excluded patients listed with Model for End‐Stage Liver Disease (MELD) exception scores and those listed for multiorgan transplant, except for liver–kidney transplant. A subset of data from the waiting list was used to create a mortality prediction model at 90 days after listing with 105,140 patients. A total of 28 variables were selected for model creation. The data were split using random sampling into training, validation, and test data sets in a 60:20:20 ratio. The performance of the model was assessed using area under the receiver operating curve (AUC‐ROC) and area under the precision‐recall curve (AUC‐PR). AUC‐ROC for 90‐day mortality was 0.936 (95% confidence interval [CI], 0.934–0.937), and AUC‐PR was 0.758 (95% CI, 0.754–0.762). The NN 90‐day mortality model outperformed MELD‐based models for both AUC‐ROC and AUC‐PR. The 90‐day mortality model specifically identified more waitlist deaths with a higher recall (sensitivity) of 0.807 (95% CI, 0.803–0.811) versus 0.413 (95% CI, 0.409–0.418; p < 0.001). The performance metrics were compared by breaking the test data set into multiple patient subsets by ethnicity, gender, region, age, diagnosis group, and year of listing. The NN 90‐day mortality model outperformed MELD‐based models across all subsets in predicting mortality. In conclusion, organ allocation based on NN modeling has the potential to decrease waitlist mortality and lead to more equitable allocation systems in LT.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.